{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:41:28Z","timestamp":1771461688848,"version":"3.50.1"},"reference-count":19,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010133","name":"Aarne Koskelo Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010133","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Finnish Cardiac Foundation"},{"name":"Department of Emergency Medicine"},{"name":"Services of Helsinki University Hospital"},{"DOI":"10.13039\/100010133","name":"Aarne Koskelo Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010133","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Soluble urokinase\u2013type plasminogen activator receptor (suPAR) is a biomarker reflecting the level of immune activation. It has been shown to have prognostic value in acute coronary syndrome and heart failure as well as in critical illness. Considering the complex pathophysiology of cardiogenic shock (CS), we hypothesized suPAR might have prognostic properties in CS as well. The aim of this study was to assess the kinetics and prognostic utility of suPAR in CS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>SuPAR levels were determined in serial plasma samples (0\u201396\u2005h) from 161 CS patients in the prospective, observational, multicentre CardShock study. Kinetics of suPAR, its association with 90-day mortality, and additional value in risk-stratification were investigated. The median suPAR-level at baseline was 4.4 [interquartile range (IQR) 3.2\u20136.6)] ng\/mL. SuPAR levels above median were associated with underlying comorbidities, biomarkers reflecting renal and cardiac dysfunction, and higher 90-day mortality (49% vs. 31%; P\u2009=\u20090.02). Serial measurements showed that survivors had significantly lower suPAR levels at all time points compared with nonsurvivors. For risk stratification, suPAR at 12\u2005h (suPAR12h) with a cut-off of 4.4\u2005ng\/mL was strongly associated with mortality independently of established risk factors in CS: OR 5.6 (95% CI 2.0\u201315.5); P\u2009=\u20090.001) for death by 90 days. Adding suPAR12h &amp;gt; 4.4\u2005ng\/mL to the CardShock risk score improved discrimination identifying high-risk patients originally categorized in the intermediate-risk category.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>SuPAR associates with mortality and improves risk stratification independently of other previously known risk factors in CS patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjacc\/zuac096","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T05:18:52Z","timestamp":1660195132000},"source":"Crossref","is-referenced-by-count":1,"title":["Soluble urokinase-type plasminogen activator receptor improves early risk stratification in cardiogenic shock"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9838-1248","authenticated-orcid":false,"given":"Mari","family":"Hongisto","sequence":"first","affiliation":[{"name":"Emergency Medicine, University of Helsinki, Department of Emergency Medicine and Services, Helsinki University Hospital , Helsinki , Finland"}]},{"given":"Johan","family":"Lassus","sequence":"additional","affiliation":[{"name":"Cardiology, University of Helsinki and Heart and Lung Centre, Helsinki University Hospital , Helsinki , Finland"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3406-243X","authenticated-orcid":false,"given":"Tuukka","family":"Tarvasm\u00e4ki","sequence":"additional","affiliation":[{"name":"Cardiology, University of Helsinki and Heart and Lung Centre, Helsinki University Hospital , Helsinki , Finland"}]},{"given":"Jordi","family":"Sans-Rosell\u00f3","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital de la Santa Creu I Sant Pau, Universitat Aut\u00f2noma de Barcelona, Biomedical Research Institute IIB-Sant Pau, CIBER-CV , Spain"}]},{"given":"Heli","family":"Tolppanen","sequence":"additional","affiliation":[{"name":"Cardiology, University of Helsinki and Heart and Lung Centre, Helsinki University Hospital , Helsinki , Finland"}]},{"given":"Anu","family":"Kataja","sequence":"additional","affiliation":[{"name":"Emergency Medicine, University of Helsinki, Department of Emergency Medicine and Services, Helsinki University Hospital , Helsinki , Finland"}]},{"given":"Toni","family":"J\u00e4ntti","sequence":"additional","affiliation":[{"name":"Cardiology, University of Helsinki and Heart and Lung Centre, Helsinki University Hospital , Helsinki , Finland"}]},{"given":"Tuija","family":"Sabell","sequence":"additional","affiliation":[{"name":"Cardiology, University of Helsinki and Heart and Lung Centre, Helsinki University Hospital , Helsinki , Finland"}]},{"given":"Marek","family":"Banaszewski","sequence":"additional","affiliation":[{"name":"National Institute of Cardiology , Warsaw , Poland"}]},{"given":"Jose","family":"Silva-Cardoso","sequence":"additional","affiliation":[{"name":"CINTESIS\u2014Center for Health Technology and Services Research, Faculty of Medicine, University of Porto, S\u00e3o Jo\u00e3o University Medical Center, Faculty of Medicine, University of Porto , Porto , Portugal"}]},{"given":"John","family":"Parissis","sequence":"additional","affiliation":[{"name":"ER and Heart Failure Unit, Attikon University Hospital, National and Kapodestrian University of Athens , Athens , Greece"}]},{"given":"Raija","family":"Jurkko","sequence":"additional","affiliation":[{"name":"Cardiology, University of Helsinki and Heart and Lung Centre, Helsinki University Hospital , Helsinki , Finland"}]},{"given":"Jindrich","family":"Spinar","sequence":"additional","affiliation":[{"name":"St. Ann university hospital and Medical faculty Masaryk University , Brno , Czech Republic"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7164-4733","authenticated-orcid":false,"given":"Maaret","family":"Castr\u00e9n","sequence":"additional","affiliation":[{"name":"Emergency Medicine, University of Helsinki, Department of Emergency Medicine and Services, Helsinki University Hospital , Helsinki , Finland"}]},{"given":"Alexandre","family":"Mebazaa","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, Inserm 942\u2014MASCOT , Paris , France"}]},{"given":"Josep","family":"Masip","sequence":"additional","affiliation":[{"name":"Research Direction, Consorci Sanitari Integral, University of Barcelona , Barcelona , Spain"}]},{"given":"Veli Pekka","family":"Harjola","sequence":"additional","affiliation":[{"name":"Emergency Medicine, University of Helsinki, Department of Emergency Medicine and Services, Helsinki University Hospital , Helsinki , Finland"}]},{"name":"for the CardShock Study Investigators and the GREAT Network","sequence":"additional","affiliation":[]}],"member":"286","published-online":{"date-parts":[[2022,8,11]]},"reference":[{"key":"2022081105184364200_zuac096-B1","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1001\/archinte.165.14.1643","article-title":"Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock","volume":"165","author":"Kohsaka","year":"2005","journal-title":"Arch Intern Med"},{"key":"2022081105184364200_zuac096-B2","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1055\/s-0037-1616105","article-title":"Release of soluble urokinase receptor from vascular cells","volume":"86","author":"Chavakis","year":"2001","journal-title":"Thromb Haemost"},{"key":"2022081105184364200_zuac096-B3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1155\/2009\/504294","article-title":"suPAR: the molecular crystal ball","volume":"27","author":"Thun\u00f8","year":"2009","journal-title":"Dis Markers"},{"key":"2022081105184364200_zuac096-B4","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1007\/s00134-012-2613-1","article-title":"Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review","volume":"38","author":"Backes","year":"2012","journal-title":"Intensive Care Med"},{"key":"2022081105184364200_zuac096-B5","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jcrc.2013.08.005","article-title":"Soluble urokinase-type plasminogen activator receptor as a prognostic biomarker in critically ill patients","volume":"29","author":"Donadello","year":"2014","journal-title":"J Crit Care"},{"key":"2022081105184364200_zuac096-B6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2796.2010.02252.x","article-title":"Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population","volume":"268","author":"Eugen-Olsen","year":"2010","journal-title":"J Intern Med"},{"key":"2022081105184364200_zuac096-B7","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1056\/NEJMoa1506362","article-title":"Soluble urokinase receptor and chronic kidney disease","volume":"373","author":"Hayek","year":"2015","journal-title":"N Engl J Med"},{"key":"2022081105184364200_zuac096-B8","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1373\/clinchem.2013.203778","article-title":"Soluble urokinase plasminogen activator receptor for risk prediction in patients admitted with acute chest pain","volume":"59","author":"Lyngb\u00e6k","year":"2013","journal-title":"Clin Chem"},{"key":"2022081105184364200_zuac096-B9","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jchf.2016.12.008","article-title":"Soluble urokinase-type plasminogen activator receptor improves risk prediction in patients with chronic heart failure","volume":"5","author":"Koller","year":"2017","journal-title":"JACC Heart Fail"},{"key":"2022081105184364200_zuac096-B10","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJMoa1911481","article-title":"Soluble urokinase receptor and acute kidney injury","volume":"382","author":"Hayek","year":"2020","journal-title":"N Engl J Med"},{"key":"2022081105184364200_zuac096-B11","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/ejhf.260","article-title":"Clinical picture and risk prediction of short-term mortality in cardiogenic shock","volume":"17","author":"Harjola","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2022081105184364200_zuac096-B12","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2022081105184364200_zuac096-B13","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/cc10037","article-title":"Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients","volume":"15","author":"Koch","year":"2011","journal-title":"Crit Care"},{"key":"2022081105184364200_zuac096-B14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/MPA.0000000000001247","article-title":"Correlation of Serum and ascitic fluid soluble form urokinase plasminogen activator receptor levels with patient complications, disease severity, inflammatory markers, and prognosis in patients with severe acute pancreatitis","volume":"48","author":"Long","year":"2019","journal-title":"Pancreas"},{"key":"2022081105184364200_zuac096-B15","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.amjcard.2012.08.008","article-title":"Usefulness of soluble urokinase plasminogen activator receptor to predict repeat myocardial infarction and mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention","volume":"110","author":"Lyngb\u00e6k","year":"2012","journal-title":"AM J Cardiol"},{"key":"2022081105184364200_zuac096-B16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40560-019-0381-5","article-title":"Neutrophils are a main source of circulating suPAR predicting outcome in critical illness","volume":"7","author":"Gussen","year":"2019","journal-title":"J Intensive Care"},{"key":"2022081105184364200_zuac096-B17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/SHK.0000000000000756","article-title":"Infectious complications and immune\/inflammatory response in cardiogenic shock patients: A prospective observational study","volume":"47","author":"Parenica","year":"2017","journal-title":"Shock"},{"key":"2022081105184364200_zuac096-B18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jcrc.2021.12.005","article-title":"Peripheral blood neutrophil-to-lymphocyte ratio is associated with mortality across the spectrum of cardiogenic shock severity","volume":"68","author":"Jentzer","year":"2022","journal-title":"J Crit Care"},{"key":"2022081105184364200_zuac096-B19","doi-asserted-by":"crossref","first-page":"e005618","DOI":"10.1161\/CIRCOUTCOMES.119.005618","article-title":"Epidemiology of shock in contemporary cardiac intensive care units","volume":"12","author":"Berg","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"}],"container-title":["European Heart Journal. Acute Cardiovascular Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjacc\/advance-article-pdf\/doi\/10.1093\/ehjacc\/zuac096\/45322535\/zuac096.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjacc\/advance-article-pdf\/doi\/10.1093\/ehjacc\/zuac096\/45322535\/zuac096.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T05:19:22Z","timestamp":1660195162000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjacc\/advance-article\/doi\/10.1093\/ehjacc\/zuac096\/6660742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,11]]},"references-count":19,"URL":"https:\/\/doi.org\/10.1093\/ehjacc\/zuac096","relation":{},"ISSN":["2048-8726","2048-8734"],"issn-type":[{"value":"2048-8726","type":"print"},{"value":"2048-8734","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,11]]},"article-number":"zuac096"}}